Amedisys (AMED) PT Lifted to $28 at Piper Jaffray; 'Hold' Maintained
Tweet Send to a Friend
Piper Jaffray analyst Kevin Ellich bumped his price target on Amedisys (NASDAQ: AMED) to $28.00 (from $24.00) following in-line Q4 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
